Fundz

Akston Biosciences Corp reported raising $3.39 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEDec 30, 2020$3.4M of $6M raised

Amount Raised

$3.39 Million

$3.39 Million sold, per SEC Form D (first sale Dec 30, 2020)

Round Type

Seed

BeverlyBiotechnology

Quick answer

Akston raised $3.39 Million in a Seed round, dated December 30, 2020. Akston is based in Beverly, Massachusetts, United States.

How much did Akston raise?
Akston raised $3.39 Million in a Seed round on December 30, 2020.
What does Akston do?
Akston is a biotech company built for pets.
Where is Akston based and how big is it?
Akston is based in Beverly, Massachusetts, United States. Fundz records about 68 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Akston that raised within 45 days of this round, from Fundz verified event records.

  • BigHat Biosciences raised $19M on February 12, 2021.
  • Acrivon Therapeutics raised $16M on February 12, 2021.
  • Outlook Therapeutics raised $4M (Seed) on February 12, 2021.
  • TMRW Life Sciences raised $20M on February 12, 2021.
  • Oragenics raised $21M (Series C) on February 12, 2021.
  • OncBioMune Pharmaceuticals, Inc raised $400K (Seed) on February 12, 2021.

Who to call at Akston, and when

A new round usually means Akston is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Akston raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Akston, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Akston. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Akston

Location

100 CUMMINGS CENTER SUITE 454C

Beverly, Massachusetts, United States

About

Akston is a biotech company built for pets. Powered by its proprietary Ambifect® Fc-fusion protein platform, Akston develops targeted and immune-enhancing biologics that aim to reduce treatment frequency while improving efficacy. With a fully integrated structure and in-house GMP biologics manufacturing, Akston accelerates development from discovery to commercialization - bringing innovation to veterinarians and pets faster.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Akston raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Akston's next move

See what Strategic adds

Akston raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.